Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $24.27. The company's market cap stands at 138.41B, with a P/E ratio of 18.62 and a dividend yield of 7.08%.
On 2026-06-27, Pfizer(PFE) stock moved within a range of $23.70 to $24.35. With shares now at $24.27, the stock is trading +2.4% above its intraday low and -0.3% below the session's peak.
Trading activity shows a volume of 59.96M, compared to an average daily volume of 57.45M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.11.
PFE News
Key Points Pfizer is one of the world's largest drug companies. It has a long history of navigating the industry's ups and downs. Pfizer is struggling today,...
Looking for stocks that pay dividends? You may have come across pharmaceutical outfit Pfizer (PFE +2.62%) in your search. After all, its forward-looking dividen...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Unlock powerful investing tools and data-driven ins...
Analyst ratings
59%
of 29 ratingsMore PFE News
Pfizer (NYSE:PFE) and Merck received European Commission approval for the Keytruda plus Padcev regimen in perioperative bladder cancer. The decision covers pat...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more c...
Key Points AbbVie is aggressively expanding its pipeline to offset the impact of biosimilar competition for its top-selling drugs. Pfizer is utilizing substan...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE:PFE) Ibrance (palbociclib) regimen for frontline maintenance for metastat...
Pfizer (PFE) announced the U.S. Food and Drug Administration approved Ibrance in combination with trastuzumab, with or without pertuzumab, and endocrine therapy...
The U.S. Food and Drug Administration on Wednesday approved a label expansion for Pfizer’s (PFE) breast cancer therapy, palbociclib, marketed as Ibrance. Accor...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more c...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.